This Week’s Top Value Stocks: (PFE)(MYL)

Videos
Looking for the best value stocks? Tracey Ryniec, Stock Strategist at Zacks Investment Research, discusses two stocks that might be worth a closer look by value investors: Pfizer (PFE) and Mylan NV (MYL).

Both companies have forward P/Es well below the average of the S&P 500, which is now a sky-high level of 18. They also are in favor with analysts, as 2015 and 2016 earnings estimates have been moving higher.

They both have been returning value to shareholders. Pfizer is expected to continue to pay its juicy dividend, even after its merger with Allergan. Mylan recently announced a $1 billion share buyback program.

But what else should investors take away from these two companies? Watch our short video below to learn more about these value stocks!

Pfizer: http://www.zacks.com/stock/quote/PFE?cid=CS-YOUTUBE-FT-VID
Mylan: http://www.zacks.com/stock/quote/MYL?cid=CS-YOUTUBE-FT-VID

Follow us on StockTwits: http://stocktwits.com/ZacksResearch
Follow us on Twitter: https://twitter.com/ZacksResearch
Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Articles You May Like

ProMedica loses last investment-grade rating in Moody’s cut to junk
Does the Ethereum Merge offer a new destination for institutional investors?
Kaufman Hall bulks up with acquisition of Claro Healthcare
Munis walloped on front end, $2B more outflows
Total crypto market cap shows strength even after the Merge and Federal Reserve rate hike